- UPSpace Home
- →
- Health Sciences
- →
- Pharmacology
- →
- Research Articles (Pharmacology)
- →
- Browsing Research Articles (Pharmacology) by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Research Articles (Pharmacology) by Subject "Trastuzumab"
Now showing items 1-4 of 4
-
(OpenJournals Publishing, 2011-03)The human epidermal growth factor receptor 2 (HER2) is overexpressed in HER2-positive breast cancer. This confers characteristics associated with an overall poor prognosis, with early metastases to major visceral sites and ...
-
(Dove Medical Press, 2013-06-15)INTRODUCTION: Despite trastuzumab having enhanced selectivity for human epidermal growth factor receptor 2 (HER-2) overexpressing breast cancer cells, treatment is hampered by interindividual variation and tumors with high ...
-
(BioMed Central, 2013-10-11)BACKGROUND: Human epidermal growth factor receptor-2 (Her-2) is over expressed in approximately 25-30% of all primary breast tumors resulting in a distinctive breast cancer subtype associated with a poor prognosis and a ...
-
(Oriental Scientific Publishing Company, 2018)The 15-25% of breast cancers that overexpress human epidermal growth factor receptor type 2 (Her-2) are aggressive and more difficult to treat with conventional chemotherapy than their oestrogen receptor positive (ER+) ...
Now showing items 1-4 of 4